Investing-News.Com
Information for Investors

ALBANY MOLECULAR, (AMRI) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

ALBANY MOLECULAR, (AMRI) Stock Rating Learn More

Our Overall Rating on Albany Molecular Research Inc,  AMRI is BUY
StockPickReport.Com research suggests AMRI's price will move higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

With StockPickReport.Com's "Buy" rating, stochastic and "relative strength" numbers may agree, but not in all cases.

Investors, traders, and other market participants may find this a good opportunity to buy AMRI, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains (although those gains may not be as signficant as gains experienced in conjunction with a "Strong Buy" rating).

Trading volume seems to be falling and AMRI's closing price moved up during the week before this rating was initiated.

Our BUY Rating on AMRI was issued on 03/25/08

ALBANY MOLECULAR Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces ALBANY MOLECULAR Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in ALBANY MOLECULAR buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on ALBANY MOLECULAR. This software is specially designed to give precision entry and exit points on ALBANY MOLECULAR, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When ALBANY MOLECULAR Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even ALBANY MOLECULAR, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: stock screens 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

AMRI settles patent dispute with rivals (at bizjournals.com)

Israel Stocks: Market lower; Teva settles patent case, wins a round in another (at MarketWatch)

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosur (EDGAR Online)

Teva, Barr settle patent dispute with Sanofi (AP)

Teva, Barr, Sanofi, Albany Molecular settle patent disputes (at MarketWatch)

AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRA® and ALLEGRA®D-12 U.S. Patent Dispute (Business Wire)

Albany Molecular Research, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha)

ALBANY MOLECULAR RESEARCH INC Financials (EDGAR Online Financials)

ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

AMRIs net income jumps 250% in 3Q (at bizjournals.com)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.